Project Name COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility
Project Number 55012-001
Country / Economy Afghanistan
Project Status Active
Project Type / Modality of Assistance Grant
Source of Funding / Amount
Grant 0786-AFG: COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility
Asian Development Fund US$ 50.00 million
Operational Priorities OP1: Addressing remaining poverty and reducing inequalities
OP2: Accelerating progress in gender equality
OP7: Fostering regional cooperation and integration
Sector / Subsector

Health / Disease control of communicable disease

Gender Effective gender mainstreaming
Description TBD
Project Rationale and Linkage to Country/Regional Strategy TBD

Vulnerable groups are protected from COVID-19 (National Vaccination Deployment Plan

The spread of severe acute respiratory syndrome coronavirus 2 is reduced, and confidence of citizens is restored (ADB's Support to Enhance COVID-19 Vaccine Access)

Project Outcome
Description of Outcome

Priority populations vaccinated against COVID-19

Progress Toward Outcome
Implementation Progress
Description of Project Outputs

COVID-19 vaccines procured and delivered to designated points

Vaccine program implementation capacity strengthened

Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide
Safeguard Categories
Environment C
Involuntary Resettlement C
Indigenous Peoples C
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation
Responsible ADB Officer ADB Disclosure
Responsible ADB Department Central and West Asia Department
Responsible ADB Division Afghanistan Resident Mission
Concept Clearance -
Fact Finding 10 Feb 2021 to 15 Mar 2021
MRM 02 Mar 2021
Approval 20 Apr 2021
Last Review Mission -
Last PDS Update 21 Apr 2021

Grant 0786-AFG

Approval Signing Date Effectivity Date Closing
Original Revised Actual
20 Apr 2021 09 May 2021 07 Jun 2021 30 Jun 2023 - -
Financing Plan Grant Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 52.00 Cumulative Contract Awards
ADB 50.00 10 Jul 2022 0.00 0.00 0%
Counterpart 2.00 Cumulative Disbursements
Cofinancing 0.00 10 Jul 2022 0.00 0.00 0%
This page was generated from /projects/55012-001/main on 06 June 2023

Source URL: